Allseason Enterprises LLC – Trademark Portfolio
Entity Type: 16
Allseason Enterprises LLC holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 27 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 19 trademarks are registered and 2 are pending. Notable registered marks include RENOUTH, GINKSENG, MEGAMALE, Q-DEFEND, and MULTIMANE. The owner is based in Saint Charles, IL.
3833 E Main St
Saint Charles, IL 60174
Showing of trademarks Trademarks
Trademark Classifications
Allseason Enterprises LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Allseason Enterprises LLC have?
Allseason Enterprises LLC has 28 U.S. trademarks filed with the USPTO. Of these, 19 registered, 2 pending, 7 abandoned.
What trademark classes does Allseason Enterprises LLC file in?
Allseason Enterprises LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Allseason Enterprises LLC's most well-known trademarks?
Allseason Enterprises LLC's registered trademark portfolio includes well-known marks such as RENOUTH, GINKSENG, MEGAMALE, Q-DEFEND, and MULTIMANE. These are among 19 currently registered trademarks in the portfolio.
What is Allseason Enterprises LLC's trademark registration success rate?
Allseason Enterprises LLC has a 73% trademark registration rate, with 19 out of 26 resolved applications resulting in successful registration. Currently, 2 applications are pending review.